Nasivin Erwachsene Und Schulkinder (Oxymetazoline Hydrochloride)

Oxymetazoline, the active ingredient in Nasivin Erwachsene Und Schulkinder, is a alpha‑adrenergic agonist presented as a nasal spray for intranasal use. It provides temporary relief of nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and school‑age children.

GNH USA supplies Nasivin Erwachsene Und Schulkinder as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline is indicated for nasal congestion arising from upper‑respiratory conditions.

- Common cold: reduces nasal blockage and improves airflow. - Sinusitis: alleviates mucosal swelling to ease sinus drainage. - Allergic rhinitis: diminishes congestion caused by allergen exposure.

Oxymetazoline may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing or mild headache. - Bitter or metallic taste. - Transient epistaxis (nosebleed).

Serious or Rare Side Effects: - Rebound nasal congestion with prolonged use. - Elevated blood pressure or hypertension. - Tachycardia or cardiac arrhythmias. - Severe nasal ulceration. - Allergic reactions such as rash or angioedema.

Before using Nasivin, consider the following safety measures.

- Limit duration of use: avoid continuous use beyond three days to prevent rebound congestion. - Cardiovascular caution: use with care in patients with hypertension or heart disease. - Age restriction: not recommended for children under six years of age. - Pregnancy and lactation: consult a healthcare professional before use. - Drug interactions: review concomitant medications for potential interactions. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline can interact with several systemic agents; monitoring is advised.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: additive sympathomimetic effects. - Other sympathomimetic drugs (e.g., ephedrine): may cause excessive vasoconstriction.

Moderate Interactions (Monitor Closely):\n- Beta‑blockers: possible attenuation of cardiovascular response. - Antihypertensive agents: monitor blood pressure for additive effects. - Combined nasal decongestants: increased risk of systemic side effects.